Presentation is loading. Please wait.

Presentation is loading. Please wait.

Reh cells, 24 hours c-Myc Ac-p53 b-actin

Published byLinnéa Karlsson Modified over 5 years ago

Similar presentations

Presentation on theme: "Reh cells, 24 hours c-Myc Ac-p53 b-actin"— Presentation transcript:

1 Reh cells, 24 hours c-Myc Ac-p53 b-actin
SRT2183, uM pano, nM c-Myc Ac-p53 b-actin SUPPLEMENTAL FIGURE 3

2 NALM-6 cells, 24 hours c-Myc Ac-p53 b-actin 0 1 5 10 0 0 1 5 1
SRT2183, uM pano, nM c-Myc Ac-p53 b-actin SUPPLEMENTAL FIGURE 3

3 MOLT-4 cells, 24 hours c-Myc P-H2A.X Ac-H4 (K8) b-actin
SRT2183, uM pano, nM c-Myc P-H2A.X Ac-H4 (K8) b-actin SUPPLEMENTAL FIGURE 3

Download ppt "Reh cells, 24 hours c-Myc Ac-p53 b-actin"

Similar presentations

Supplementary Figure 1. Caspase 8 expression and activation and Fas expression in NSCLC and normal lung cell lines. A Western blot analysis of DR4 and.

Supplementary Figure 1. Caspase 8 expression and activation and Fas expression in NSCLC and normal lung cell lines. A Western blot analysis of DR4 and.
Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination.

Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination.
Supplemental Figure 1 A No. at risk T3 530 483 304 185 50 T2 559 545 373 228 76 T1 540 532 375 208 64.

Supplemental Figure 1 A No. at risk T T T
Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
H1299 Vector H1648 TUSC2 TUSC2 -ER 2.3 uM ER H1299 Vector TUSC2 TUSC2 -ER 2.3 uM ER H1299 Vector H1648 TUSC2 TUSC2 -ER 2.3 uM ER H1299 Vector TUSC2 TUSC2.

H1299 Vector H1648 TUSC2 TUSC2 -ER 2.3 uM ER H1299 Vector TUSC2 TUSC2 -ER 2.3 uM ER H1299 Vector H1648 TUSC2 TUSC2 -ER 2.3 uM ER H1299 Vector TUSC2 TUSC2.
The Cell Division Cycle

The Cell Division Cycle
Supplemental Figure 1. 1000 cells/ well DLD-1 ALDH+/CD133+ DLD-1 ALDH- /CD133- Supplemental Figure 2.

Supplemental Figure cells/ well DLD-1 ALDH+/CD133+ DLD-1 ALDH- /CD133- Supplemental Figure 2.
Supplemental Results Online Figure S1. Norepinephrine increases ROS production. (A): H9c2 cells were treated with 10  M norepinephrine and intracellular.

Supplemental Results Online Figure S1. Norepinephrine increases ROS production. (A): H9c2 cells were treated with 10  M norepinephrine and intracellular.
Cell Biology. Outline Organization of body systems – Organ – Tissue – Cell— How do we study biology? – Why should we? Research question in biology.

Cell Biology. Outline Organization of body systems – Organ – Tissue – Cell— How do we study biology? – Why should we? Research question in biology.
D Day 2Day 1Day 4Day 6 Day 1 Day 2 Day 4 Day 6 Biopsy Injury D0 D1 D2 D3 D4 D5 D6 Wound monitoring by endoscope & Intrarectal adminstration of LGG or HBSS.

D Day 2Day 1Day 4Day 6 Day 1 Day 2 Day 4 Day 6 Biopsy Injury D0 D1 D2 D3 D4 D5 D6 Wound monitoring by endoscope & Intrarectal adminstration of LGG or HBSS.
Supplementary Table S1 Clinical exposure for palbociclib, fulvestrant and chemotherapeutic agents used in this study. Palbociclib (1)*Paclitaxel (2)*Doxorubicin.

Supplementary Table S1 Clinical exposure for palbociclib, fulvestrant and chemotherapeutic agents used in this study. Palbociclib (1)*Paclitaxel (2)*Doxorubicin.
Supplemental Figure S1 ResidueMass Delta Mass Sequence Mascot Ion Score 62 - 701064.640.04R.DFGLLVFVR.K49 125 - 133994.680.04K.IPALDLLIK.L56 156 - 163939.550.04K.FYGELALK.K34.

Supplemental Figure S1 ResidueMass Delta Mass Sequence Mascot Ion Score R.DFGLLVFVR.K K.IPALDLLIK.L K.FYGELALK.K34.
Supplemental Figure 1. A. GCN1L1B. DSPC. RCN3 D. AKR1B10E. PDIA4F. CTSB.

Supplemental Figure 1. A. GCN1L1B. DSPC. RCN3 D. AKR1B10E. PDIA4F. CTSB.
A B Figure S1 (related to Figure 1). BETi-tolerant A375 and NOMO-1 cells show an abrogated apoptotic response to BETi. C D E F.

A B Figure S1 (related to Figure 1). BETi-tolerant A375 and NOMO-1 cells show an abrogated apoptotic response to BETi. C D E F.
Farmer et al Supplementary Figure 1 KU0058684 PARP-1 IC 50 = 3.2nM KU0058948 PARP-1 IC 50 = 3.4nM KU0051529 PARP-1 IC 50 = 730nM a b 0 0.001 0.01 0.1 1.

Farmer et al Supplementary Figure 1 KU PARP-1 IC 50 = 3.2nM KU PARP-1 IC 50 = 3.4nM KU PARP-1 IC 50 = 730nM a b
Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Keriayn N. Smith, Amar M. Singh, Stephen Dalton Cell Stem Cell Volume 7, Issue.

Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Keriayn N. Smith, Amar M. Singh, Stephen Dalton Cell Stem Cell Volume 7, Issue.
Figure1 HER2 SKBr3 PC3 A. SKBr3 cells Figure1 0 0.03 0.3 3 30 (µM) 120 100 80 60 40 20 0 Penetratin control % of control 0 0.03 0.3 3 30 (µM) 120 100.

Figure1 HER2 SKBr3 PC3 A. SKBr3 cells Figure (µM) Penetratin control % of control (µM)
Figure Molecular Biology of the Cell (© Garland Science 2008)

Figure Molecular Biology of the Cell (© Garland Science 2008)

Similar presentations

Ads by Google